Health Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species June 24, 2021
Health Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation May 13, 2021
Health Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application May 11, 2021
Health Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD May 11, 2021
Health Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC April 30, 2021
Editorspicks Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants April 26, 2021
Editorspicks Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 Million March 16, 2021
Search
